New Delhi, Sept. 11 -- India's largest biopharmaceutical company, Biocon Limited, on Wednesday, announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics Inc (BGI), according to an exchange filing.

Kiran Mazumdar-Shaw, Chairperson, Biocon Group, said, "Biocon's first U.S. FDA approved formulations facility in New Jersey marks a new chapter in our journey of global expansion. More than a milestone, it is a reaffirmation of our purpose to serve patients wherever they are. Governor Phil Murphy's presence at the inauguration highlights the importance of Biocon's role in fostering innovation, creating job opportunities, and strengthening the U.S. healthcare eco...